Quick Answer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported R&D Expense of $97.31 million for fiscal year 2025.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $97.31M | -27.9% |
| 2024 | $134.92M | -27.9% |
| 2023 | $187.17M | -3.0% |
| 2022 | $193.00M | +70.9% |
| 2021 | $112.90M | +76.0% |
| 2020 | $64.15M | +7.6% |
| 2019 | $59.63M | -4.7% |
| 2018 | $62.59M | -4.2% |
| 2017 | $65.32M | -3.4% |
| 2016 | $67.62M | +11.9% |
| 2015 | $60.44M | +25.3% |
| 2014 | $48.23M | +6.7% |
| 2013 | $45.22M | -5.1% |
| 2012 | $47.62M | -37.4% |
| 2011 | $76.08M | -32.0% |
| 2010 | $111.82M | +47.4% |
| 2009 | $75.88M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.85M | -10.5% | +1.4% |
| June 30, 2025 | $22.53M | -41.5% | -22.5% |
| March 31, 2025 | $29.05M | -33.1% | +13.9% |
| September 30, 2024 | $25.52M | -46.3% | -33.7% |
| June 30, 2024 | $38.48M | -16.7% | -11.4% |
| March 31, 2024 | $43.45M | -11.2% | -8.5% |
| September 30, 2023 | $47.51M | +0.9% | +2.9% |
| June 30, 2023 | $46.17M | -8.3% | -5.7% |
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. showed a decrease of -27.9% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s r&d expense has grown by 28.2% (from $75.88 million to $97.31 million).
- The most recent figure is from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: